Literature DB >> 25542394

Determinants of discrepancies in detection and comparison of the prognostic significance of left ventricular hypertrophy by electrocardiogram and cardiac magnetic resonance imaging.

Ljuba Bacharova1, Haiying Chen2, E Harvey Estes3, Anton Mateasik1, David A Bluemke4, Joao A C Lima5, Gregory L Burke6, Elsayed Z Soliman7.   

Abstract

Despite the low sensitivity of the electrocardiogram (ECG) in detecting left ventricular hypertrophy (LVH), ECG-LVH is known to be a strong predictor of cardiovascular risk. Understanding reasons for the discrepancies in detection of LVH by ECG versus imaging could help improve the diagnostic ability of ECG. We examined factors associated with false-positive and false-negative ECG-LVH, using cardiac magnetic resonance imaging (MRI) as the gold standard. We also compared the prognostic significance of ECG-LVH and MRI-LVH as predictors of cardiovascular events. This analysis included 4,748 participants (mean age 61.9 years, 53.5% females, 61.7% nonwhites). Logistic regression with stepwise selection was used to identify factors associated with false-positive (n = 208) and false-negative (n = 387), compared with true-positive (n = 208) and true-negative (n = 4,041) ECG-LVH, respectively. A false-negative ECG-LVH status was associated with increased odds of Hispanic race/ethnicity, current smoking, hypertension, increased systolic blood pressure, prolongation of QRS duration, and higher body mass index and with lower odds of increased ejection fraction (model-generalized R(2) = 0.20). A false-positive ECG-LVH status was associated with lower odds of black race, Hispanic race/ethnicity, minor ST-T abnormalities, increased systolic blood pressure, and presence of any major electrocardiographic abnormalities (model-generalized R(2) = 0.29). Both ECG-LVH and MRI-LVH were associated with an increased risk of cardiovascular disease events (hazard ratio 1.51, 95% confidence interval 1.03 to 2.20 and hazard ratio 1.81, 95% confidence interval 1.33 to 2.46, respectively). In conclusion, discrepancy in LVH detection by ECG and MRI can be relatively improved by considering certain participant characteristics. Discrepancy in diagnostic performance, yet agreement on predictive ability, suggests that LVH by ECG and LVH by imaging are likely to be two distinct but somehow related phenotypes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25542394      PMCID: PMC4312708          DOI: 10.1016/j.amjcard.2014.11.037

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  27 in total

1.  The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. 1949.

Authors:  M Sokolow; T P Lyon
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

2.  Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.

Authors:  B R Davis; J A Cutler; D J Gordon; C D Furberg; J T Wright; W C Cushman; R H Grimm; J LaRosa; P K Whelton; H M Perry; M H Alderman; C E Ford; S Oparil; C Francis; M Proschan; S Pressel; H R Black; C M Hawkins
Journal:  Am J Hypertens       Date:  1996-04       Impact factor: 2.689

3.  The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.

Authors:  B Dahlöf; R Devereux; U de Faire; F Fyhrquist; T Hedner; H Ibsen; S Julius; S Kjeldsen; K Kristianson; O Lederballe-Pedersen; L H Lindholm; M S Nieminen; P Omvik; S Oparil; H Wedel
Journal:  Am J Hypertens       Date:  1997-07       Impact factor: 2.689

4.  Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy.

Authors:  D Levy; S B Labib; K M Anderson; J C Christiansen; W B Kannel; W P Castelli
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

5.  Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity.

Authors:  Shunsuke Natori; Shenghan Lai; J Paul Finn; Antoinette S Gomes; W Gregory Hundley; Michael Jerosch-Herold; Gregory Pearson; Shantanu Sinha; Andrew Arai; Joao A C Lima; David A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2006-06       Impact factor: 3.959

6.  Abnormal action potential conduction in isolated human hypertrophied left ventricular myocardium.

Authors:  H McIntyre; C H Fry
Journal:  J Cardiovasc Electrophysiol       Date:  1997-08

7.  The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study.

Authors:  David A Bluemke; Richard A Kronmal; João A C Lima; Kiang Liu; Jean Olson; Gregory L Burke; Aaron R Folsom
Journal:  J Am Coll Cardiol       Date:  2008-12-16       Impact factor: 24.094

8.  Conduction velocity and gap junction resistance in hypertrophied, hypoxic guinea-pig left ventricular myocardium.

Authors:  M Cooklin; W R Wallis; D J Sheridan; C H Fry
Journal:  Exp Physiol       Date:  1998-11       Impact factor: 2.969

9.  Left ventricular hypertrophy as a risk factor in arterial hypertension.

Authors:  W B Kannel
Journal:  Eur Heart J       Date:  1992-09       Impact factor: 29.983

Review 10.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

View more
  29 in total

Review 1.  Is Left Ventricular Hypertrophy a Valid Therapeutic Target?

Authors:  Jeremy Earl Brooks; Elsayed Z Soliman; Bharathi Upadhya
Journal:  Curr Hypertens Rep       Date:  2019-05-20       Impact factor: 5.369

2.  Left ventricular hypertrophy by ECG versus cardiac MRI as a predictor for heart failure.

Authors:  Abdullahi O Oseni; Waqas T Qureshi; Mohamed F Almahmoud; Alain G Bertoni; David A Bluemke; William G Hundley; Joao A C Lima; David M Herrington; Elsayed Z Soliman
Journal:  Heart       Date:  2016-08-02       Impact factor: 5.994

3.  Global ECG Measures and Cardiac Structure and Function: The ARIC Study (Atherosclerosis Risk in Communities).

Authors:  Tor Biering-Sørensen; Muammar Kabir; Jonathan W Waks; Jason Thomas; Wendy S Post; Elsayed Z Soliman; Alfred E Buxton; Amil M Shah; Scott D Solomon; Larisa G Tereshchenko
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-03

4.  The Romhilt-Estes left ventricular hypertrophy score and its components predict all-cause mortality in the general population.

Authors:  E Harvey Estes; Zhu-Ming Zhang; Yabing Li; Larisa G Tereschenko; Elsayed Z Soliman
Journal:  Am Heart J       Date:  2015-04-13       Impact factor: 4.749

5.  Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART.

Authors:  Bharathi Upadhya; Michael V Rocco; Nicholas M Pajewski; Tim Morgan; Joseph Blackshear; William Greg Hundley; Suzanne Oparil; Elsayed Z Soliman; Debbie L Cohen; Craig A Hamilton; Monique E Cho; William J Kostis; Vasilios Papademetriou; Carlos J Rodriguez; Dominic S Raj; Ray Townsend; Sujethra Vasu; Sara Zamanian; Dalane W Kitzman
Journal:  Hypertension       Date:  2019-07-01       Impact factor: 10.190

6.  Short-term repeatability of electrocardiographic criteria of left ventricular hypertrophy.

Authors:  Michelle L Meyer; Elsayed Z Soliman; Dominique Drager; Gerardo Heiss
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-09-09       Impact factor: 1.468

7.  Individual components of the Romhilt-Estes left ventricular hypertrophy score differ in their prediction of cardiovascular events: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  E Harvey Estes; Zhu-Ming Zhang; Yabing Li; Larisa G Tereshchenko; Elsayed Z Soliman
Journal:  Am Heart J       Date:  2015-10-03       Impact factor: 4.749

Review 8.  Clinical Diagnosis of Electrical Versus Anatomic Left Ventricular Hypertrophy: Prognostic and Therapeutic Implications.

Authors:  Aapo L Aro; Sumeet S Chugh
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-04

9.  Comprehensive First-Line Magnetic Resonance Imaging in Hypertension: Experience From a Single-Center Tertiary Referral Clinic.

Authors:  Amy E Burchell; Jonathan C L Rodrigues; Max Charalambos; Laura E K Ratcliffe; Emma C Hart; Julian F R Paton; Andreas Baumbach; Nathan E Manghat; Angus K Nightingale
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-19       Impact factor: 3.738

10.  Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation?

Authors:  Cesare Cuspidi; Rita Facchetti; Carla Sala; Michele Bombelli; Marijana Tadic; Guido Grassi; Giuseppe Mancia
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-05-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.